Effects of the MTHFR C677T polymorphism on prostate specific antigen and prostate cancer

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2275-2278

  Küçükhüseyin, Özlem ^a   Kurnaz, Özlem ^a   Akadam Teker, A Basak ^a   Narter, Fehmi ^b   Yilmaz Aydoǧan, Hülya ^a   Isbir, Turgay ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

MTHFR; Polymorphism; Prostate cancer; PSA; RFLP

Indexed keywords

FOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROSTATE SPECIFIC ANTIGEN;

AGED; ALLELE; ARTICLE; BINDING SITE; BLOOD; ENZYMOLOGY; EXON; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; PROSTATE TUMOR;

AGED; ALLELES; BINDING SITES; EXONS; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84866331870     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bailey LB, Gregory JF (1999). Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr, 129, 919-22.
2. Blount BC, Mack MM, Wehr CM, et al (1997). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA, 94, 3290-5.
3. Choi SW, Mason JB (2002). Folate status: effects on pathways of colorectal carcinogenesis. J Nutr, 132, 2413-8.
4. Cicek MS, Nock NL, Li L, et al (2004). Relationship between MTHFR C677T and A1298C genotypes & Haplotypes and Prostate Cancer Risk and Aggressiveness. Cancer Epidemiol Biomarkers Prev, 13, 1331-6.
5. De Mattia E, Toffoli G (2009). C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation. Eur J Cancer, 45, 1333-51.
6. Friso S, Choi SW, Girelli D, et al (2002). A common mutation in the 5,10methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA, 99, 5606-11.
7. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
8. Frosst P, Rosenblatt DS, Rozen R (1995). Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet, 56, 1052-9.
9. Gambert S (2001) Screening for prostate cancer. International Urology and Nephrology, 33, 249-57.
10. Gemmati D, Ongaro A, Scapoli GL, et al (2004). Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev, 13, 787-94.
11. Goyette P, Pai A, Milos R, et al (1998). Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome, 9, 652-6.
12. Heijmans BT, Boer JM, Suchiman HE, et al (2003). A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res, 63, 1249-53.
13. Ilic D, O'Connor D, Green S (2011). Screening for prostate cancer: A Cochrane systematic review. BJU Int, 107, 882-91.
14. Kimura F, Franke KH, Steinhoff C, et al (2000). Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate, 45, 225-31.
15. Krajinovic M, Lamothe S, Labuda D, et al (2004). Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood, 103, 252-7.
16. Lasalvia-Prisco E, Cucchi S, Vázquez J, et al (2003). Serum markers variation consistent with autoschizis induced by ascorbic acid-menadione in patients with prostate cancer. Med Oncol, 20, 45-52.
17. Mao R, Fan Y, Jin Y, et al (2008) Methylene tetrahydrofolate reductase gene polymorphisms and lung cancer: a meta-analysis. J Hum Genet, 53, 340-8.
18. Miller SA, Dykes DD, Polesky HF (1998). A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res, 16, 1215.
19. Parkin D, Bray F, Devesa S (2001). Cancer burden in the year 2000. The global picture. Eur J Cancer, 37, S4-66
20. Paz MF, Avila S, Fraga MF (2002). Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res, 62, 4519-24.
21. Pereira TV, Rudnicki M, Pereira AC, et al (2006). 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 15, 1956-63.
22. Puri SK, Si L, Fan CY, et al (2005) Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol, 26, 12-7.
23. Reljic A, Simundic AM, Topic E, et al (2007). The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Clin Biochem, 40, 981-5.
24. Rosenblatt DS (2001) Methylenetetrahydrofolate reductase. Clin Invest Med, 24, 56-9.
25. Shrubsole MJ, Gao YT, Cai Q, et al (2004). MTHFR polymorphisms, diatery folate intake, and breast cancer risk: result from the Shangai Breast Cancer study. Cancer Epidemiol Biomarkers Prev, 13, 190-6.
26. Signal R, Ferdinand L, Das PM, et al (2004). Polymorphisms in the MTHFR gene and prostate cancer risk. Int J Oncol 25, 1465-1471.
27. Sohn KJ, Croxford R, Yates Z, et al (2004). Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5- fluorouracil and methotrexate. J Natl Cancer Inst, 96, 134-44.
28. Stern LL, Mason JB, Selhub J, et al (2000). Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev, 9, 849-53.
29. Wang J, Sasco A, Fu C, et al (2008). Aberrant DNA methylation of p16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 17, 118-25.